Paper41563458
The enigma of vascular dementia: current state and emerging perspectives.
Jellinger KA. J Neural Transm (Vienna), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. The enigma of vascular dementia: current state and emerging perspectives. Papers, record 41563458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41563458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References425
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23728651 | Rivastigmine for vascular cognitive impairment. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23728651 | PubMed |
| 2 | 35835295 | A clinical research of 11cases of human umbilical cord mesenchymal stem cells for curing senile vascular dementia. | Transpl Immunol | 2022 | https://conductscience.org/library/papers/35835295 | PubMed |
| 3 | 40043785 | Transcriptomic and network analysis identifies shared pathways across Alzheimer's disease and vascular dementia. | Brain Res | 2025 | https://conductscience.org/library/papers/40043785 | PubMed |
| 4 | 38252700 | Shared Proteins and Pathways of Cardiovascular and Cognitive Diseases: Relation to Vascular Cognitive Impairment. | J Proteome Res | 2024 | https://conductscience.org/library/papers/38252700 | PubMed |
| 5 | 23440834 | Cerebrolysin for vascular dementia. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23440834 | PubMed |
| 6 | 21778438 | Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. | Stroke | 2011 | https://conductscience.org/library/papers/21778438 | PubMed |
| 7 | 27733032 | Adult Stem Cell Therapy for Stroke: Challenges and Progress. | J Stroke | 2016 | https://conductscience.org/library/papers/27733032 | PubMed |
| 8 | 36145294 | Discovering a Multi-Component Combination against Vascular Dementia from Danshen-Honghua Herbal Pair by Spectrum-Effect Relationship Analysis. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36145294 | PubMed |
| 9 | 35356856 | Current Concepts of Mixed Pathologies in Neurodegenerative Diseases. | Can J Neurol Sci | 2023 | https://conductscience.org/library/papers/35356856 | PubMed |
| 10 | 40289686 | Imaging brain fluid dynamics and waste clearance involving perivascular spaces in cerebral small vessel disease. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40289686 | PubMed |
| 11 | 23867200 | Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. | Lancet Neurol | 2013 | https://conductscience.org/library/papers/23867200 | PubMed |
| 12 | 21556678 | Vascular cognitive impairment: disease mechanisms and therapeutic implications. | Neurotherapeutics | 2011 | https://conductscience.org/library/papers/21556678 | PubMed |
| 13 | 36324710 | Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention. | Cereb Circ Cogn Behav | 2021 | https://conductscience.org/library/papers/36324710 | PubMed |
| 14 | 22341035 | Cerebral microinfarcts: the invisible lesions. | Lancet Neurol | 2012 | https://conductscience.org/library/papers/22341035 | PubMed |
| 15 | 14650915 | Cholinergic modulation of the cortical microvascular bed. | Prog Brain Res | 2004 | https://conductscience.org/library/papers/14650915 | PubMed |
| 16 | 22720454 | Diagnosing and managing vascular dementia. | Practitioner | 2012 | https://conductscience.org/library/papers/22720454 | PubMed |
| 17 | 35606149 | Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL. | Neurology | 2022 | https://conductscience.org/library/papers/35606149 | PubMed |
| 18 | 34938197 | Identification of miRNA and Their Regulatory Effects Induced by Total Flavonoids From Dracocephalum moldavica in the Treatment of Vascular Dementia. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34938197 | PubMed |
| 19 | 40519128 | A nomogram including serum iron metabolism-related indicator and cerebral microbleeds for predicting vascular cognitive impairment in patients. | J Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40519128 | PubMed |
| 20 | 34800332 | The effects of blood pressure on post stroke cognitive impairment: BP and PSCI. | J Clin Hypertens (Greenwich) | 2021 | https://conductscience.org/library/papers/34800332 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42978823 | Treatment of vascular dementia based on neuroprotection and neural repair strategies: from pathophysiology to natural products. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42978823 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41563458
GET https://conductscience.org/api/papers/v1/41563458/references?page=2